Skip to main
AKRO
AKRO logo

Akero Therapeutics Inc (AKRO)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy AKRO Stock

About Akero Therapeutics Inc (AKRO)

Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and protein...read more
Market cap$4.43B
Today's volume2.23M
Revenue (TTM)
Avg. daily volume1.51M
EBITDA (TTM)-$306.33M
Open$52.19
Price / earnings ratio-14.84x
Today's range$52.19 - $55.83
Debt / equity3.37x
52 week range$21.02 - $58.4
5 year debt / equity2.84x
Beta (LTM)1.05x
Interest coverage-61.14x
Dividend & yield$0.00 (0.00%)
Current ratio16.8x
Ex-dividend date
Next earningsAug 8, 2025
Dividend payable date

AKRO Stock Rating

What analysts recommend for AKRO stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 69%
Buy 31%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for AKRO stock is $4.44B

The current P/E ratio for AKRO stock is -14.84

The 52-week high for AKRO stock is $58.40. The current AKRO stock price $undefined is 100.00% below its 52-week high

The 52-week low for AKRO stock is $21.02. The current AKRO stock price $undefined has increased 100.00% from its 52-week low

No, the AKRO stock does not pay dividends to its shareholders

The target price for AKRO stock is $63.85 based on the average of what a group of analyst think AKRO stock could be worth at a future date. This is not a prediction by Public.com

How to buy AKRO stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AKRO stock

    Navigate to the Explore page. Then, type AKRO into the search bar. When you see AKRO stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AKRO stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Akero Therapeutics Inc Stock Earnings

The value each AKRO share was expected to gain vs. the value that each AKRO share actually gained.

AKRO (AKRO) reported Q1 2025 earnings per share (EPS) of -$0.90, beating estimates of -$0.99 by 9.09%. In the same quarter last year, AKRO's earnings per share (EPS) was -$0.90. AKRO is expected to release next earnings on 08/08/2025, with an earnings per share (EPS) estimate of $0.

Buy AKRO Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.